Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-08-001379
Filing Date
2008-02-29
Accepted
2008-02-29 16:39:15
Documents
12
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 INVERNESS MEDICAL INNOVATIONS, INC. b68107ime10vk.htm 10-K 1934760
2 EX-3.4 FIRST AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE b68107imexv3w4.htm EX-3.4 5366
3 EX-10.31 RULES OF INVERNESS MEDICAL INNOVATIONS, INC. b68107imexv10w31.htm EX-10.31 103912
4 EX-10.40 AMENDMENT NO.6 2001 STOCK OPTION AND INCENTIVE PLAN b68107imexv10w40.htm EX-10.40 2199
5 EX-10.41 AMENDMENT NO.7 2001 STOCK OPTION AND INCENTIVE PLAN b68107imexv10w41.htm EX-10.41 2024
6 EX-21.1 LIST OF SUBSIDIARIES OF THE COMPANY b68107imexv21w1.htm EX-21.1 34229
7 EX-23.1 CONSENT OF BDO SEIDMAN, LLP b68107imexv23w1.htm EX-23.1 1945
8 EX-31.1 SECTION 302 CERTIFICATION OF CEO b68107imexv31w1.htm EX-31.1 5788
9 EX-31.2 SECTION 302 CERTIFICATION OF CFO b68107imexv31w2.htm EX-31.2 6036
10 EX-32.1 SECTION 906 CERTIFICATION OF CEO & CFO b68107imexv32w1.htm EX-32.1 4427
11 GRAPHIC b68107imb6810701.gif GRAPHIC 9727
12 GRAPHIC b68107imb6810702.gif GRAPHIC 3737
  Complete submission text file 0000950135-08-001379.txt   2120994
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
INVERNESS MEDICAL INNOVATIONS INC (Filer) CIK: 0001145460 (see all company filings)

EIN.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16789 | Film No.: 08656348
SIC: 2835 In Vitro & In Vivo Diagnostic Substances